Daniel Schmolze

13PUBLICATIONS
77CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomedical instrumentationClinical midwiferyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Dec 23, 2025
YAP1 Dysfunction Promotes Molecular Properties Linked to Breast Cancer Susceptibility.

Tara Fresques, Jennifer C Lopez, Deborah Hussey

|Dec 15, 2025
Addressing Global Disparities in Breast Cancer by Transforming Surgical Pathology in Ethiopia: Early Implementation of Immunohistochemistry.

Lesley Taylor, Rebecca A Nelson, Teketel Tadesse Geremew

|Oct 01, 2025
Association Between the Volume Transfer Constant (K<sup>trans</sup>) From Dynamic Contrast-Enhanced Perfusion MR and HER2 Status in Breast Cancer Brain Metastases.

Jonathan R Young, Luke N Ledbetter, Julie A Ressler

|Apr 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Oct 04, 2024
Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.

Weihua Guo, Jiayi Tan, Lei Wang

Pageof 3

Frequent Collaborators

6 joint publications

Peter P Lee

3 joint publications

Shawn T Solomon

3 joint publications

Susan E Yost

3 joint publications

Hyejin Cho